Skip to content
RDL Network logo
LBA42 Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: The NADINA trial — M.W. Lucas (2024) | RDL Network